NLS Pharmaceutics Ltd. Ordinary Shares (NLSP) Dividend History

NLS Pharmaceutics Ltd. is a biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) disorders. The company works on enhancing drug delivery and improving treatment options for conditions such as schizophrenia, depression, and other neurological illnesses. Its pipeline includes formulations aimed at addressing unmet medical needs in the CNS therapeutic space.

Dividend History

NLS Pharmaceutics Ltd. Ordinary Shares currently does not pay dividends

Company News

  • NLS Pharmaceutics is launching a preclinical program to evaluate Mazindol ER as a potential treatment for fentanyl dependence, a major global health crisis. Mazindol ER targets multiple neurotransmitter systems implicated in opioid addiction, offering a non-opioid alternative.

    Benzinga
  • Kadimastem has called for a special general meeting of shareholders to approve the merger with NLS Pharmaceutics. The merger aims to create a combined Nasdaq-traded biotechnology company with a robust pipeline of advanced therapies.

    Benzinga
  • Read this before investing in penny stocks The post Investing in Penny Stocks With $1k, What to Know appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: GOVX
  • Use these top tips to navigate the bull and bear penny stocks market The post Navigating Bull and Bear Penny Stocks Markets, 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: MBIO
  • Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20 per unit. U Power shares dipped 54% to $0.7090 on Monday. Here are some other stocks moving in today's mid-day session. Gainers EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares jumped 211.3% to $20.58 after the company announced the Phase 2 DAVIO 2 trial of EYP-1901 in wet AMD achieved all primary and secondary endpoints. Hawaiian Holdings, Inc. (NASDAQ: HA) shares climbed 187% to $14.03 after Alaska Air Group, Inc. (NYSE: ALK) announced plans to acquire the company in a deal worth $1.9 billion. Alterity Therapeutics Limited (NASDAQ: ATHE) shares climbed 156% to $4.25 after the company announced that ATHE434 new data in a Parkinson's disease primate model were presented at the Future of Parkinson's Disease Conference 2023. SilverSun Technologies, Inc. (NASDAQ: SSNT) gained 142.7% to $8.91 after the company announced Jacobs Private Equity II and minority co-investors will invest $1 billion in the company. Bit Brother Limited (NASDAQ: BETS) rose 86.3% to $0.0723 after surging 43% on Friday. Bit Brother said it purchased 3300 units of Antminer S19 miners, injecting powerful momentum into its Bitcoin mining operations. Lucy Scientific Discovery Inc. (NASDAQ: LSDI) shares jumped 72.2% to $0.3530. View, Inc. (NASDAQ: VIEW) gained 52.3% to $1.5701. Mawson Infrastructure Group, Inc. (NASDAQ: MIGI) rose 29.8% to $1.17. Marpai, Inc. (NASDAQ: MRAI) jumped 28.3% to $1.9250. CEL-SCI Corporation (NYSE: CVM) surged 25.6% to $2.6009. The UK'S National Institute for Health and Care Excellence selected CEL-SCI's Multikine as a potential new ...

    Benzinga
Dividend data last updated 06/07/2025 08:14:07 UTC